Literature DB >> 29648884

Association between Pulmonary Hypertension and Clinical Outcomes in Hospitalized Patients with Sickle Cell Disease.

Manyoo A Agarwal1, Mahek Shah2, Brijesh Patel2, Vikki G Nolan3, Guy L Reed4, Ronald J Oudiz5, Gaurav Choudhary6,7, Bradley A Maron8,9.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29648884      PMCID： PMC6118030          DOI： 10.1164/rccm.201802-0261LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  12 in total

1.  Haematological determinants of cardiac involvement in adults with sickle cell disease.

Authors:  Thibaud Damy; Diane Bodez; Anoosha Habibi; Aziz Guellich; Stéphane Rappeneau; Jocelyn Inamo; Soulef Guendouz; Justine Gellen-Dautremer; Serge Pissard; Sylvain Loric; Orianne Wagner-Ballon; Bertrand Godeau; Serge Adnot; Jean-Luc Dubois-Randé; Luc Hittinger; Frédéric Galactéros; Pablo Bartolucci
Journal:  Eur Heart J       Date:  2015-10-29       Impact factor: 29.983

2.  Cerebrovascular disease associated with sickle cell pulmonary hypertension.

Authors:  Gregory J Kato; Matthew Hsieh; Roberto Machado; James Taylor; Jane Little; John A Butman; Tanya Lehky; John Tisdale; Mark T Gladwin
Journal:  Am J Hematol       Date:  2006-07       Impact factor: 10.047

Review 3.  Pulmonary complications of sickle cell disease.

Authors:  Mark T Gladwin; Elliott Vichinsky
Journal:  N Engl J Med       Date:  2008-11-20       Impact factor: 91.245

4.  Beast of Pulmonary Arterial Hypertension Burden.

Authors:  Stephen C Mathai; Vallerie V McLaughlin
Journal:  JAMA Cardiol       Date:  2016-12-01       Impact factor: 14.676

5.  An official American Thoracic Society clinical practice guideline: diagnosis, risk stratification, and management of pulmonary hypertension of sickle cell disease.

Authors:  Elizabeth S Klings; Roberto F Machado; Robyn J Barst; Claudia R Morris; Kamal K Mubarak; Victor R Gordeuk; Gregory J Kato; Kenneth I Ataga; J Simon Gibbs; Oswaldo Castro; Erika B Rosenzweig; Namita Sood; Lewis Hsu; Kevin C Wilson; Marilyn J Telen; Laura M Decastro; Lakshmanan Krishnamurti; Martin H Steinberg; David B Badesch; Mark T Gladwin
Journal:  Am J Respir Crit Care Med       Date:  2014-03-15       Impact factor: 21.405

6.  National trends in hospitalizations for sickle cell disease in the United States following the FDA approval of hydroxyurea, 1998-2008.

Authors:  Maureen M Okam; Shimon Shaykevich; Benjamin L Ebert; Alan M Zaslavsky; John Z Ayanian
Journal:  Med Care       Date:  2014-07       Impact factor: 2.983

7.  Health insurance and racial disparities in pulmonary hypertension outcomes.

Authors:  Kishan S Parikh; Kathryn A Stackhouse; Stephen A Hart; Thomas M Bashore; Richard A Krasuski
Journal:  Am J Manag Care       Date:  2017-08       Impact factor: 2.229

8.  Redefining pulmonary hypertension.

Authors:  Bradley A Maron; Evan L Brittain; Gaurav Choudhary; Mark T Gladwin
Journal:  Lancet Respir Med       Date:  2017-12-18       Impact factor: 30.700

9.  Hospitalization rates and costs of care of patients with sickle-cell anemia in the state of Maryland in the era of hydroxyurea.

Authors:  Sophie Lanzkron; Carlton Haywood; Jodi B Segal; George J Dover
Journal:  Am J Hematol       Date:  2006-12       Impact factor: 10.047

Review 10.  Health Disparities in Patients with Pulmonary Arterial Hypertension: A Blueprint for Action. An Official American Thoracic Society Statement.

Authors:  Arunabh Talwar; Joe G N Garcia; Halley Tsai; Matthew Moreno; Tim Lahm; Roham T Zamanian; Roberto Machado; Steven M Kawut; Mona Selej; Stephen Mathai; Laura Hoyt D'Anna; Sonu Sahni; Erik J Rodriquez; Richard Channick; Karen Fagan; Michael Gray; Jessica Armstrong; Josanna Rodriguez Lopez; Vinicio de Jesus Perez
Journal:  Am J Respir Crit Care Med       Date:  2017-10-15       Impact factor: 21.405
View more
  1 in total

1.  Toward Early Diagnosis of Pulmonary Hypertension: Lessons From Oz.

Authors:  Bradley A Maron; Bradley M Wertheim
Journal:  J Am Coll Cardiol       Date:  2019-06-04       Impact factor: 24.094
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.